Portrait of Ann Petru
  • Telehealth visits
bch logo

Ann Petru, MD

Pediatric Infectious DiseasesDivision Director, Infectious Diseases, Oakland
Medical Director, HIV/AIDS Program, Oakland
Pediatric Infectious Disease Oakland
877-822-4453
Portrait of Ann Petru
Portrait of Ann Petru
bch logo

Ann Petru, MD

Pediatric Infectious DiseasesDivision Director, Infectious Diseases, Oakland
Medical Director, HIV/AIDS Program, Oakland
Pediatric Infectious Disease Oakland
877-822-4453

On this page

About me

Dr. Ann Petru is a specialist who cares for children with serious infections, including pediatric HIV and AIDS. Her professional interests include infection control and medical ethics.

Petru earned her medical degree from UCSF. At UCSF Benioff Children's Hospital Oakland, she completed a residency in pediatrics, serving as chief resident, followed by a fellowship in pediatric infectious diseases.

In her free time, Petru coordinates a local Masters Swimming program and participates in a book group made up of UCSF doctors. She enjoys talking to her neighbors and cherishes time with them and with her grandchildren.

Education & training

Board certification

  • Pediatric Infectious Disease, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Fellowship

  • Infectious Diseases, UCSF Benioff Children's Hospital--Oakland

Residency

  • Pediatrics, UCSF Benioff Children's Hospital--Oakland

Degree

  • MD, University of CA at San Francisco

Academic Title

  • Health Sciences Clinical Professor

My expertise

Locations

    My research

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.